NNVC250117P2500
- 1.24
- 0.000.00%
Nanoviricides Newsroom
NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025
NanoViricides CEO Discusses Groundbreaking Broad-spectrum Antiviral Treatment | NYSE-A:NNVC
NanoViricides Is in a Great Position to Fight Potential Bird Flu Pandemic With a Drug That the Mercurial H5N1 Influenza A Virus Is Unlikely to Escape
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.
NanoViricides CEO Highlights Urgency of H5N1 Preparedness as Cases Rise in North America | NYSE-A:NNVC
Trump Nominates Marty Makary For FDA Commissioner
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Sell-off of US vaccine stocks intensifies! Analyst: Little Kennedy brings uncertainty to the entire industry.
1. On Friday Eastern Time, vaccine manufacturers' stocks plummeted as Donald Trump selected vaccine skeptic Kennedy as Health Secretary, causing industry uncertainty. Moderna, Novavax, Pfizer, and other stock prices were all affected. 2. Analysts pointed out that Kennedy's anti-vaccine stance may weaken public trust in vaccines, leading to a decrease in the vaccination rate in the USA, increasing the risk of outbreaks of diseases such as measles and whooping cough.
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.
NanoViricides: Fiscal Q1 Earnings Snapshot
Nanoviricides | 10-Q: Q1 2025 Earnings Report
NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am
NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology
NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy
NanoViricides to Present at the Global AMR Summit 2024 Tomorrow
NanoViricides Says Made 'Significant Progress' in NV-387 Regulatory Advancement
NanoViricides Plans to Advance NV-387 Into Phase II Clinical Trials
NanoViricides, Inc. Has Filed Its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID
NanoViricides Prepares for Phase II Trials for Antiviral NV-387 | NYSE-A:NNVC
Nanoviricides | 10-K: FY2024 Annual Report